搜索临床试验以:含可待因的泰诺
总计18228个结果
-
Universidad Nacional Autonoma de MexicoHospital General Regional #1 IMSS, Queretaro México; Clínica Hospital Dr. Ismael Vázquez Ortiz... 和其他合作者未知
-
Y-mAbs TherapeuticsMemorial Sloan Kettering Cancer Center终止
-
BioPharmX, Inc.完全的
-
Denver Health and Hospital AuthorityUniversity of Colorado, Denver; Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare... 和其他合作者撤销
-
McNeil Consumer Healthcare Division of McNEIL-PPC...完全的
-
Peking University Third Hospital完全的腰椎间盘突出症 | 腰椎管狭窄症 | 腰椎神经根病中国
-
Denver Health and Hospital AuthorityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.完全的
-
British Columbia Cancer AgencyBiocompatibles UK Ltd完全的
-
Federal University of Rio Grande do SulCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.完全的
-
University of MichiganBlue Cross Blue Shield of Michigan Foundation完全的
-
Wageningen University and ResearchNexira; Roquette Frères; Bioiberica; Ingredion Incorporated; Winclove Probiotics B.V.; Naturex; Ministery... 和其他合作者完全的
-
Rothman Institute Orthopaedics未知
-
University of ChicagoNational Cancer Institute (NCI)完全的伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 缓解期成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
South Australian Health and Medical Research InstituteWomen's and Children's Hospital, Australia; Flinders Medical Centre; Royal North Shore Hospital; Mater Mothers' Hospital 和其他合作者主动,不招人
-
University of Santiago de CompostelaLacer, S.A.完全的
-
Nexgen Pharma, IncPharmaceutical Research Unit, Jordan完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人复发性甲状腺癌 | 低分化甲状腺癌 | IV 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺乳头状癌 AJCC v7 | IVA 期甲状腺滤泡性癌 AJCC v7 | IVA 期甲状腺乳头状癌 AJCC v7 | IVB 期甲状腺滤泡性癌 AJCC v7 | IVB 期甲状腺乳头状癌 AJCC v7 | IVC 期甲状腺滤泡性癌 AJCC v7 | IVC 期甲状腺乳头状癌 AJCC v7 | 转移性甲状腺癌美国
-
Thomas Jefferson University未知